Mydecine Innovations Group Engages ethica CRO as Contract Research Organization Partner for Phase 2A PTSD Clinical Trials Psychedelics Investing
Universal Ibogaine Engages The Conscious Fund for Corporate Advisory Services Pharmaceutical Investing
Seelos Therapeutics Announces the Selection of SLS-005 for the HEALEY ALS Platform Trial for Amyotrophic Lateral Sclerosis Led by the Harvard Medical School Psychedelics Investing
Numinus Wellness Announces National Expansion with Acquisition of Montreal-Based Mindspace Wellbeing, a Full-service Well-being Organization and Pioneer in Psychedelic Programming Cannabis Investing News
Mydecine Innovations Group Engages the ProPharma Group to Proceed with FDA Filings and Approval for Novel Research and Multiple Phase Clinical Trials Psychedelics Investing
Hollister Biosciences Inc. Signs Exclusive Agreement with Easyriders to Design, Manufacture and Produce a National Cannabis Product Line Psychedelics Investing
Seelos Therapeutics Raises $10 Million In Private Placement of Senior Secured Convertible Note Psychedelics Investing
